Asensus Surgical, Inc.

NYSEAM:ASXC Stock Report

Market Cap: US$67.7m

Asensus Surgical Past Earnings Performance

Past criteria checks 0/6

Asensus Surgical has been growing earnings at an average annual rate of 8.5%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 24.6% per year.

Key information

8.5%

Earnings growth rate

61.7%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-24.6%
Return on equity-234.7%
Net Margin-914.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Asensus Surgical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSEAM:ASXC Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 239-783637
30 Sep 236-793737
30 Jun 237-803734
31 Mar 237-793633
31 Dec 227-763529
30 Sep 227-743527
30 Jun 227-713625
31 Mar 227-643522
31 Dec 218-623319
30 Sep 217-603017
30 Jun 215-592817
31 Mar 215-602717
31 Dec 203-602717
30 Sep 203-603018
30 Jun 204-1433619
31 Mar 207-1494221
31 Dec 199-1544722
30 Sep 1915-1474924
30 Jun 1919-694623
31 Mar 1922-834322
31 Dec 1824-624022
30 Sep 1820-1313721
30 Jun 1815-1503521
31 Mar 1810-1303220
31 Dec 177-1453022
30 Sep 174-832724
30 Jun 175-572526
31 Mar 173-1222328
31 Dec 162-1202029
30 Sep 161-1201730
30 Jun 160-1211430
31 Mar 160-501231
31 Dec 150-471130
30 Sep 150-41827
30 Jun 150-39829
31 Mar 150-40830
31 Dec 140-38728
30 Sep 140-38827
30 Jun 141-37821
31 Mar 141-31715
31 Dec 131-28613
30 Sep 132-24510
30 Jun 132-1658

Quality Earnings: ASXC is currently unprofitable.

Growing Profit Margin: ASXC is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ASXC is unprofitable, but has reduced losses over the past 5 years at a rate of 8.5% per year.

Accelerating Growth: Unable to compare ASXC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ASXC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.5%).


Return on Equity

High ROE: ASXC has a negative Return on Equity (-234.73%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.